Actuate Therapeutics, Inc. (ACTU)

Actuate Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	161	155	-	-
Enterprise Value	154	142	-	-
Last Close Price	7.02	7.96	-	-
PB Ratio	-	1492.25	-	-
P/TBV Ratio	-	1492.25	-	-
Quick Ratio	0.71	0.98	0.43	4.71
Current Ratio	0.73	1.05	0.43	4.71
Return on Equity (ROE)	-	-	-442.40%	-
Return on Assets (ROA)	-348.95%	-255.41%	-132.96%	-
Return on Capital (ROIC)	-	-	-279.06%	-
Earnings Yield	-15.34%	-17.55%	-	-
Buyback Yield / Dilution	-1044.18%	-483.48%	-18.54%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q